Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.3.2024MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))18.3.2024R
 20.3.2024MEDOCHEMIE Ltd. (MOE)67569MABRON 50 mg (cps dur 20x50 mg (blis.Al/PVC))18.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)23887Paracetamol Kabi 10 mg/ml (sol inf 10x100 ml/1000 mg (liek.inj.skl.))15.4.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)5281CSmofKabiven extra Nitrogen (emu inf 4x1518 ml (vak Biofin))1.4.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)10086Neodolpasse (sol inf 10x250 ml (fľ.skl.))25.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)5868DIbuprofen Kabi 400 mg (sol inf 40x400 mg/100 ml (fľ.LDPE))21.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)58629NUTRAMIN VLI (sol inf 10x500 ml (fľ.skl.inf.))20.3.2024O
 20.3.2024Viatris Limited (VIM)5804CSeizpat 150 mg (tbl flm 56x150 mg (blis.PVC/PVDC/Al))20.3.2024O
 20.3.2024Viatris Limited (VIM)5815CSeizpat 200 mg (tbl flm 56x200 mg (blis.PVC/PVDC/Al))20.3.2024O
 20.3.2024Exeltis Slovakia s.r.o. (EET)1560DEndovelle 2 mg tablety (tbl 1x28x2 mg (blis.Al/PVC/PVDC-kalendár.bal.))20.3.2024Z
 20.3.2024B.Braun Melsungen AG (BME)26923Kaliumchlorid B. Braun 7,45 % (con inf 20x20 ml (amp.PE))20.3.2024O
 19.3.2024STADA Arzneimittel AG (STD)51958Losartan/Hydrochlorothiazid STADA 50 mg/12,5 mg (tbl flm 90x50 mg/12,5 mg (blis.PVC/PVDC/Al))25.3.2024Z
 19.3.2024STADA Arzneimittel AG (STD)5962CPregabalin STADA Arzneimittel 150 mg (cps dur 56x150 mg (blis.Al/PVC))25.3.2024R
 19.3.2024Zentiva, k.s. (ZNT-1)02479Dithiaden (tbl 20x2 mg (blis. PVC/Al))21.3.2024R
 19.3.2024Zentiva, k.s. (ZNT-1)0865EJamesi 50 mg/1000 mg (tbl flm 196x50 mg/1000 mg (blis.PVC/PVDC/Al))21.3.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)